בית חולים שערי צדק לוגו שערי צדק המרכז הרפואי שערי צדק הוא בית חולים בירושלים. נחנך ב-י\"ט בשבט תרס\"ב 27 בינואר 1902. מייסדו ומנהלו הראשון במשך 45 שנה, היה ד\"ר משה וולך, דמות מרכזית בתולדות הרפואה בתקופת היישוב. בשנת 1980 עבר בית החולים למשכנו החדש בשכונת בית וגן בירושלים רחוב שמואל בייט 12, ת.ד 3235, ירושלים 9103102 02-6666666 חזית בית החולים
דלג לתפריט הראשי (מקש קיצור n) דלג לתוכן הדף (מקש קיצור s) דלג לתחתית הדף (מקש קיצור 2)

Prof. Alejandro Sosnik

Researcher Profile Form First National Pediatric Brain Tumor Research Meeting March 9, 2025 - Jerusalem

Researcher: Prof. Alejandro Sosnik

Current Role & Affiliation

Title/Position: Professor
Institution: Department of Materials Science and Engineering, Technion Email: sosnik@technion.ac.il
Phone: 054-2252553

Prof. Sosnik investigates polymeric nanoparticles for improved pharmacotherapy of pediatric diseases.

Research Focus

● Polymeric nanoparticles for drug delivery

● Brain-targeting strategies

● Sonodynamic therapy

● Nanoformulations for clinical trials

Current Projects Related to Pediatric Brain Tumors

● Targeted nanocarriers for diffuse midline gliomas

● Sonodynamic therapy for rhabdomyosarcoma

Laboratory/Research Resources

● Advanced nanomaterial synthesis platforms

● Drug delivery systems

Collaboration Interests

● Development of brain-targeting drug delivery systems

● Nanoformulation innovations

What You Can Offer Potential Collaborators

● Expertise in nanoparticle design

● Translational drug development strategies

Selected Publications

1. Sader D, et.al. J Colloid Interface Sci. 2025 Feb 15;680(Pt B):763-775. doi: 10.1016/j.jcis.2024.11.132. Epub 2024 Nov 20.

2. Zlotver I, et.al. Glucosylated Hybrid TiO2 /Polymer Nanomaterials for Actively Targeted Sonodynamic Therapy of Cancer. Small. 2024 Jan;20(4):e2305475.

3. Awad R, et.al. Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders. Acta Pharm Sin B. 2023 May;13(5):1866-1886.

Keywords

Nanoparticles, Drug Delivery, Pediatric Cancer, Sonodynamic Therapy

Brief Bio

Dr. Alejandro Sosnik received his pharmacy degree from the University of Buenos Aires in 1994 and M.S. (equivalency) and Ph.D. degrees in applied chemistry from the Casali Institute of Applied Chemistry (The Hebrew University of Jerusalem, Israel, 2003). He completed a post doctoral training in the University of Toronto, Canada.He established a research group that works on the interface of biomaterials science, nanotechnology, and drug delivery and targeting. Recently, he has been appointed Associate Professor at the Department of Materials Science and Engineering of Technion-Israel Institute of Technology.